The Medoc TSA 2 Air is an air-cooled Quantitative Sensory Testing (QST) device used to screen for early-stage diabetic neuropathy in community settings. By delivering controlled thermal stimuli, the system evaluates small nerve fibre (A-delta and C-fibre) function, enabling healthcare professionals to detect sensory impairment long before patients present clinical symptoms like numbness in their extremities. This empowers frontline medical staff to proactively identify high-risk individuals and provide timely preventative education, such as foot care guidelines, preventing severe downstream complications including diabetic foot ulcers and amputations. Ultimately, this approach shifts the healthcare paradigm from reactive treatment to proactive prevention, significantly reducing the long-term financial burden on the public healthcare system.